Playing The Biotech Breakout With Insiders

Biotech stocks are consolidating after a breakout, with bullish insider Wall Street sentiment. AbCellera Biologics and Alpha Cognition stand out for insider buying, revenue growth, and high Seeking Alpha Quant Ratings. ABCL's Phase 2 efficacy readout for ABCL635 in Q3 and ACOG's Zunveyl sales ramp are key catalysts. Both have substantial upside per analyst targets.

Investors have plenty of crosscurrents of news and economic stats to ponder when looking for new stocks these days, but the breakout in biotech stocks is one definite that has become clear, as illustrated by the price action of iShares Biotech ETF.